Association Between MDM2 SNP309 T>G and Risk of Gastric Cancer: A Meta-analysis |
Tian, Xin
(Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University)
Tian, Ye (Department of Thoracic Surgery, the Fouth Affiliated Hospital of China Medical University) Ma, Ping (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Sui, Cheng-Guang (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Meng, Fan-Dong (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Li, Yan (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Fu, Li-Ye (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Jiang, Tao (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Wang, Yang (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) Ji, Fu-Jian (Department of General Surgery, Second Hospital of Jilin University (Disease Treatment Center of Jilin University General Surgery)) Fang, Xue-Dong (Department of General Surgery, Second Hospital of Jilin University (Disease Treatment Center of Jilin University General Surgery)) Jiang, You-Hong (Molecular Oncology Department of Cancer Research Institute, the First Affiliated Hospital, China Medical University) |
1 | Bond GL, Hu W, Bond EE, et al (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell, 119, 591-602. DOI ScienceOn |
2 | Bond GL, Hu W, Levine A (2005). A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Res, 65, 5481-4. DOI ScienceOn |
3 | Cai X, Yang M (2012). The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis. J Cancer Res Clin Oncol, 138, 555-61. DOI ScienceOn |
4 | Chen T, Yi SH, Liu XY, et al (2012). Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk. Asian Pac J Cancer Prev, 13, 4327-30. 과학기술학회마을 DOI ScienceOn |
5 | Cho YG, Choi BJ, Song JH, et al (2008). No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients. Neoplasma, 55, 256-60. |
6 | Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62. |
7 | Eischen CM, Lozano G (2009). p53 and MDM2: antagonists or partners in crime? Cancer Cell, 15, 161-2. DOI ScienceOn |
8 | Er LM, Niu WW, Xu ZB, et al (2009). Relation of MDM2 gene polymorphism and Helicobacter pylori infection to gastric cardiac carcinoma. Clin Focus, 24, 1594-7. |
9 | Er LM (2012). Relevance of MDM2 polymorphisms with esophageal squamous cell carcinoma, gastric adenocarcinoma and double primary cancers in esophagus and stomach. Modern Prev Med, 39, 3342-4. |
10 | Gajjar M, Candeias MM, Malbert-Colas L, et al (2012). The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell, 21, 25-35. DOI ScienceOn |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907. DOI ScienceOn |
13 | Zhang L, et al (2011). Association of gene polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. Chongqing Medical School. |
14 | Wang X, Yang J, et al (2009). Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients. Helicobacter, 14, 114-9. |
15 | Yang L (2006). Incidence and mortality of gastric cancer in China. World J Gastroenterol, 12, 17-20. |
16 | Yang M, Guo Y, Zhang X, et al (2007). Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis, 28, 1996-2001. DOI ScienceOn |
17 | Zhao P, Dai M, Chen W, et al (2010). Cancer trends in China. Jpn J Clin Oncol, 40, 281-5. DOI ScienceOn |
18 | Li YQ, et al (2010). Interaction of Helicobacter pylori with MDM2 SNP309 polymorphisms and susceptibility to gastric cancer studies. Nanjing Medical School. |
19 | Knappskog S, Bjornslett M, Myklebust LM, et al (2011). The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell, 19, 273-82. DOI ScienceOn |
20 | Knappskog S, Lonning PE (2011). Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk. Transcription, 2, 207-10. DOI |
21 | Liu J, Zheng Y, Lei D, et al (2011). MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis. Asian Pac J Cancer Prev, 12, 1899-903. |
22 | Ma HB, Huang T, Han F, et al (2012). Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis. Asian Pac J Cancer Prev, 13, 2841-6. 과학기술학회마을 DOI ScienceOn |
23 | Ohmiya N, Taguchi A, Mabuchi N, et al (2006). MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol, 24, 4434-40. DOI ScienceOn |
24 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
25 | Society AC (2013). Cancer Facts & Figures 2013. Atlanta: American Cancer Society. |
26 | Stolte M, Meining A (1998) Helicobacter pylori and Gastric Cancer. Oncologist, 3, 124-8. |
27 | Stommel JM, Wahl GM (2005). A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation. Cell Cycle, 4, 411-7. DOI |
![]() |